Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 421 AL 435

Research progress on carotid artery changes and cognitive impairment in Alzheimer's disease patients

Li X, Feng X, Cai A, Guo X, Li J, Liao W, Long H, Luan P.

Ageing Res Rev. 2026 Jun;118:103127. doi: 10.1016/j.arr.2026.103127. Epub 2026 Apr 3.

Electroencephalogram microstates in Alzheimer's dementia and mild cognitive impairment: A systematic review and meta-analysis

Das S, Mdawar B, Diaconescu A, Hill AT, Desarkar P, Ma C, Zrenner C, De Luca V, Zomorrodi R, Rajji TK.

Clin Neurophysiol. 2026 Jul;187:2111856. doi: 10.1016/j.clinph.2026.2111856. Epub 2026 Mar 22.

Co-pathologies and biological processes beyond amyloid-beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies

Ferreira D, Chmiela T, Eriksdotter M, Jack CR Jr, Kalpouzos G, Marseglia A, Mecocci P, Nordberg A, Religa D, Westman E.

J Intern Med. 2026 Jun;299(6):694-710. doi: 10.1111/joim.70096. Epub 2026 Apr 16.

The Role of Magnetic Resonance Spectroscopy (MRS), Diffusion-Tensor-Imaging (DTI) and Structural MRI in the Alzheimer's Disease and Mild Cognitive Impairment Diagnosis: A Review

Zecca V, Palombelli G, Vanacore N, Canese R.

J Magn Reson Imaging. 2026 Jun;63(6):1509-1545. doi: 10.1002/jmri.70296. Epub 2026 Mar 19.

Relationship between cerebrospinal fluid catecholamines levels and biomarkers of Alzheimer's disease, inflammation and neuronal injury

Portela Moreira I, Serrão P, Sequeira L, Sá MJ, Vieira-Coelho MA, Guimarães J.

Neurol Res. 2026 Jun;48(6):732-742. doi: 10.1080/01616412.2025.2542944. Epub 2025 Aug 3.

The association of ACT -17 A/T polymorphism with Alzheimer's disease: a meta-analysis

Dou C, Zhang J, Sun Y, Zhao X, Wu Q, Ji C, Gu S, Xie Y, Mao Y.

Curr Alzheimer Res. 2013 Jan;10(1):63-71.

Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease

Zhu X, Perry G, Smith MA, Wang X.

J Alzheimers Dis. 2013;33 Suppl 1(0 1):S253-62. doi: 10.3233/JAD-2012-129005.

Elucidating the triggers, progression, and effects of Alzheimer's disease

Medeiros R, Chabrier MA, LaFerla FM.

J Alzheimers Dis. 2013;33 Suppl 1:S195-210. doi: 10.3233/JAD-2012-129009.

AD gene 3-D: moving past single layer genetic information to map novel loci involved in Alzheimer's disease

Myers AJ.

J Alzheimers Dis. 2013;33 Suppl 1:S15-22. doi: 10.3233/JAD-2012-129013.

Rivastigmine in the treatment of hypersexuality in Alzheimer disease

Canevelli M, Talarico G, Tosto G, Troili F, Lenzi GL, Bruno G.

Alzheimer Dis Assoc Disord. 2013 Jul-Sep;27(3):287-8. doi: 10.1097/WAD.0b013e31825c85ae.

Alzheimer's disease-related lesions

Alafuzoff I.

J Alzheimers Dis. 2013;33 Suppl 1:S173-9. doi: 10.3233/JAD-2012-129024.

Alzheimer's disease and the "Valley Of Death": not enough guidance from human brain tissue?

Beach TG.

J Alzheimers Dis. 2013;33 Suppl 1:S219-33. doi: 10.3233/JAD-2012-129020.

Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease

Nunes MA, Viel TA, Buck HS.

Curr Alzheimer Res. 2013 Jan;10(1):104-7. doi: 10.2174/1567205011310010014.

Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease

Sagare AP, Bell RD, Zlokovic BV.

J Alzheimers Dis. 2013;33 Suppl 1(0 1):S87-100. doi: 10.3233/JAD-2012-129037.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias